BioCentury
ARTICLE | Company News

Diamyd Medical, J&J deal

June 28, 2010 7:00 AM UTC

Diamyd granted Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. unit exclusive rights to Diamyd diabetes vaccine outside Nordic countries. The recombinant human glutamic acid decarboxyla...